A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and Lenalidomide in Patients With Multiple Myeloma After Stem Cell Transplant Who Still Have Detectable Disease
Clinical trial NCT07740486 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07740486
- Sponsor
- Polish Myeloma Consortium
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2031-06-01
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.